Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells-Reference-Cited by-同舟云学术

Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells

Published:2020-08 Issue: Volume:158 Page:104682
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Landolina Nadine,Zaffran Ilan,Smiljkovic Dubravka,Serrano-Candelas Eva,Schmiedel Dominik,Friedman Sheli,Arock Michel,Hartmann Karin,Pikarsky Eli,Mandelboim Ofer,Martin Margarita,Valent Peter,Levi-Schaffer Francesca

Funder

imwell Charitable Trust

dolph and Klara Brettler Center of the Hebrew University's School of Pharmacy

srael Science Foundation

INECO-FEDER (Spain-UE);

Austrian Science Fund

Publisher

Elsevier BV

Subject

Pharmacology

Reference54 articles.

1. ITAMs versus ITIMs: striking a balance during cell regulation;Billadeau;J. Clin. Invest.,2002

2. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase;Pani;J. Exp. Med.,1996

3. SHP-1 deficient mast cells are hyperresponsive to stimulation and critical in initiating allergic inflammation in the lung;Zhang;J. Immunol.,2010

4. Regulation of acidification and apoptosis by SHP-1 and Bcl-2;Thangaraju;J. Biol. Chem.,1999

5. WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via the SHP-1-STAT3-survivin cascade;Chuang;Br. J. Pharmacol.,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Siglec7 functions as an inhibitory receptor of non-specific cytotoxic cells and can regulate the innate immune responses in a primitive vertebrate (Oreochromis niloticus);International Journal of Biological Macromolecules;2024-10

2. Mast cells and ocular surface: An update review;Experimental Eye Research;2024-08

3. Fusobacterium nucleatum subsp. nucleatum RadD binds Siglec-7 and inhibits NK cell-mediated cancer cell killing;iScience;2024-06

4. Novel Immunopharmacological Drugs for the Treatment of Allergic Diseases;Annual Review of Pharmacology and Toxicology;2024-01-23

5. The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy;Cancers;2024-01-10